Evidence map›Paper›PMID 40658195›Full record

ArticleHuman genetics2025

FBRSL1 regulates the expression of chromatin regulators BRPF1 and KAT6A.

Gina Kastens, Hanna Berger-Santangelo, Sarah Gerstner, Roser Ufartes, Michaela Mischak, Annette Borchers, Silke Pauli

Abstract read
In one paragraph

Article in Human genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gina KastensInstitute of Human Genetics, University Medical Center Göttingen, Heinrich-Düker-Weg 12, 37073, Göttingen, Germany.
Hanna Berger-SantangeloDepartment of Biology, Molecular Embryology, Marburg University, Karl-von-Frisch Str. 8, 35043, Marburg, Germany.
Sarah GerstnerDepartment of Biology, Molecular Embryology, Marburg University, Karl-von-Frisch Str. 8, 35043, Marburg, Germany.
Roser UfartesInstitute of Human Genetics, University Medical Center Göttingen, Heinrich-Düker-Weg 12, 37073, Göttingen, Germany.
Michaela MischakInstitute of Human Genetics, University Medical Center Göttingen, Heinrich-Düker-Weg 12, 37073, Göttingen, Germany.
Annette BorchersDepartment of Biology, Molecular Embryology, Marburg University, Karl-von-Frisch Str. 8, 35043, Marburg, Germany. borchers@uni-marburg.de.ORCID http://orcid.org/0000-0002-2524-5384
Silke PauliInstitute of Human Genetics, University Medical Center Göttingen, Heinrich-Düker-Weg 12, 37073, Göttingen, Germany. silke.pauli@med.uni-goettingen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FBRSL1-associated syndrome is a rare congenital malformation and intellectual disability syndrome caused by heterozygous truncating variants in Fibrosin-Like 1 (FBRSL1). While FBRSL1 is known to be involved in embryonic development, its precise molecular function remains poorly understood. Therefore, the aim of this study was to elucidate the molecular function of FBRSL1, which is thought to be essential for developmental processes, and to investigate the effect of patient-derived truncating FBRSL1 variants. Using chromatin immunoprecipitation followed by sequencing (ChIP-Seq), we show that FBRSL1 regulates the expression of epigenetic regulators. We demonstrate that FBRSL1 associates with the transcription factor Yin Yang 1 (YY1) and binds upstream of Bromodomain And PHD Finger containing 1 (BRPF1) and Lysine Acetyltransferase 6 A (KAT6A), two epigenetic regulators involved in embryonic development and linked to neurodevelopmental disorders. Furthermore, quantitative real-time PCR analysis revealed that truncating FBRSL1 variants lead to downregulation of BRPF1 and KAT6A in blood and fibroblasts derived from patients with the FBRSL1-associated syndrome. Consistently, loss of Fbrsl1 function in Xenopus laevis embryos, which results in a range of developmental abnormalities, including craniofacial and brain malformations, also leads to defects in the brpf1 and kat6a expression pattern. In summary, our findings support a function of FBRSL1 in regulating key genes involved in global epigenetic processes and embryonic development. These results provide mechanistic insights how FBRSL1 dysfunction contributes to the pathogenesis of FBRSL1-associated syndrome.

Indexed as

Adaptor Proteins, Signal TransducingHistone AcetyltransferasesIntellectual DisabilityNuclear ProteinsAnimalsBromodomain Containing ProteinsChromatinDNA-Binding ProteinsEmbryonic DevelopmentEpigenesis, GeneticGene Expression Regulation, DevelopmentalHumansXenopus laevisAdaptor Proteins, Signal TransducingBromodomain Containing ProteinsBRPF1 protein, humanChromatinDNA-Binding ProteinsHistone AcetyltransferasesKAT6A protein, humanNuclear Proteins

Identifiers

PMID40658195
PMCPMC12449339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.